GT
RMD icon

Glenmede Trust’s ResMed RMD Stock Holding History

Glenmede Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Buy
5,479
+71
+1% +$17.7K 0.01% 675
2025
Q4 		$1.3M Buy
+5,408
New +$1.38M 0.01% 656
2025
Q1 		$1.21M Sell
5,394
-137
-2% -$32K 0.01% 651
2024
Q4 		$1.26M Buy
5,531
+90
+2% +$21.7K 0.01% 643
2024
Q3 		$1.33M Sell
5,441
-57
-1% -$12.7K 0.01% 649
2024
Q2 		$1.05M Buy
5,498
+604
+12% +$123K 0.01% 676
2024
Q1 		$969K Buy
4,894
+330
+7% +$60.5K ﹤0.01% 717
2023
Q4 		$785K Buy
4,564
+2,564
+128% +$394K ﹤0.01% 766
2023
Q3 		$296K Sell
2,000
-4,173
-68% -$755K ﹤0.01% 994
2023
Q2 		$1.35M Hold
6,173
– – 0.01% 588
2023
Q1 		$1.35M Sell
6,173
-2,440
-28% -$529K 0.01% 589
2022
Q4 		$1.79M Sell
8,613
-655
-7% -$144K 0.01% 545
2022
Q3 		$2.02M Sell
9,268
-2,678
-22% -$610K 0.01% 500
2022
Q2 		$2.5M Sell
11,946
-113
-0.9% -$24.1K 0.01% 488
2022
Q1 		$2.92M Sell
12,059
-206
-2% -$49.8K 0.01% 492
2021
Q4 		$3.19M Buy
12,265
+216
+2% +$56K 0.02% 484
2021
Q3 		$3.17M Sell
12,049
-202
-2% -$55.2K 0.02% 468
2021
Q2 		$3.02M Sell
12,251
-494
-4% -$104K 0.02% 466
2021
Q1 		$2.47M Buy
12,745
+1,426
+13% +$286K 0.01% 486
2020
Q4 		$2.4M Buy
11,319
+1,122
+11% +$224K 0.01% 492
2020
Q3 		$1.75M Buy
10,197
+3,614
+55% +$667K 0.01% 508
2020
Q2 		$1.26M Buy
6,583
+3,249
+97% +$532K 0.01% 563
2020
Q1 		$516K Hold
3,334
– – ﹤0.01% 898
2019
Q4 		$516K Buy
3,334
+421
+14% +$60.7K ﹤0.01% 898
2019
Q3 		$393 Sell
2,913
-69
-2% -$9.04K ﹤0.01% 960
2019
Q2 		$363 Sell
2,982
-72
-2% -$7.98K ﹤0.01% 990
2019
Q1 		$317 Sell
3,054
-1,023
-25% -$106K ﹤0.01% 1028
2018
Q4 		$463 Buy
4,077
+2,087
+105% +$224K ﹤0.01% 871
2018
Q3 		$229K Sell
1,990
-198
-9% -$21.7K ﹤0.01% 1095
2018
Q2 		$226K Sell
2,188
-822
-27% -$83.2K ﹤0.01% 1034
2018
Q1 		$254K Hold
3,010
– – ﹤0.01% 1110
2017
Q4 		$254K Sell
3,010
-113
-4% -$9.34K ﹤0.01% 1110
2017
Q3 		$239K Buy
3,123
+146
+5% +$11.2K ﹤0.01% 1163
2017
Q2 		$214K Hold
2,977
– – ﹤0.01% 1178
2017
Q1 		$214K Hold
2,977
– – ﹤0.01% 1178
2016
Q4 		$183K Sell
2,977
-124
-4% -$7.59K ﹤0.01% 1227
2016
Q3 		$200K Buy
3,101
+476
+18% +$31.7K ﹤0.01% 1192
2016
Q2 		$165K Buy
2,625
+179
+7% +$10.6K ﹤0.01% 1229
2016
Q1 		$140K Buy
2,446
+73
+3% +$4.13K ﹤0.01% 1254
2015
Q4 		$127K Sell
2,373
-1,954
-45% -$110K ﹤0.01% 1297
2015
Q3 		$219K Buy
4,327
+2,177
+101% +$117K ﹤0.01% 1154
2015
Q2 		$120K Hold
2,150
– – ﹤0.01% 1375
2015
Q1 		$153K Buy
2,150
+100
+5% +$6.5K ﹤0.01% 1337
2014
Q4 		$114K Sell
2,050
-399
-16% -$20.8K ﹤0.01% 1481
2014
Q3 		$119K Buy
2,449
+79
+3% +$4.02K ﹤0.01% 1388
2014
Q2 		$119K Sell
2,370
-1,500
-39% -$74.3K ﹤0.01% 1346
2014
Q1 		$171K Sell
3,870
-2,255
-37% -$101K ﹤0.01% 1230
2013
Q4 		$288K Buy
6,125
+1,809
+42% +$91.6K ﹤0.01% 1035
2013
Q3 		$227K Buy
4,316
+500
+13% +$24.3K ﹤0.01% 1081
2013
Q2 		$171K Buy
+3,816
New +$181K ﹤0.01% 1137

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glenmede Trust's RMD Position: Q1 2026 in Review

Glenmede Trust increased its ResMed (RMD) stake by 1.3% in Q1 2026, buying an estimated $17.7K and bringing the position to 5,479 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #675.

Glenmede Trust first reported a position in RMD in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.19M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Glenmede Trust held 5,479 shares of ResMed worth $1.23M as of Q1 2026.
  • Glenmede Trust bought 71 ResMed shares in Q1 2026, an estimated $17.7K.
  • ResMed made up 0.01% of Glenmede Trust's portfolio in Q1 2026, its #675 holding.
  • Glenmede Trust first reported a position in ResMed in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's ResMed position peaked at $3.19M in Q4 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.